PAR TECHNOLOGY CORP 8-K/A
Research Summary
AI-generated summary
PAR Technology Amends 8-K to Disclose Shares Issued for Cardlytics Deal
What Happened
- PAR Technology Corp. filed an amendment to its Form 8-K on March 24, 2026 (original Form 8-K filed January 26, 2026) under Item 3.02 (Unregistered Sales of Equity Securities) to provide the total number of common shares issued as consideration (the “Consideration Shares”) in connection with its acquisition.
- The issuance relates to an Asset Purchase Agreement among PAR, its subsidiary DB Sub, LLC, and Cardlytics, Inc. for substantially all of Cardlytics’ point-of-sale data analytics, loyalty marketing, and retail media network business assets offered through the Bridg platform. PAR’s common stock has a par value of $0.02.
Key Details
- Filing type: Amendment to Form 8-K (Item 3.02 — Unregistered Sales of Equity Securities).
- Original 8-K filing date: January 26, 2026; Amendment filed: March 24, 2026.
- Parties: PAR Technology Corp., DB Sub, LLC (indirect, wholly owned subsidiary), and Cardlytics, Inc.
- Purpose: Amendment provides the total number of Consideration Shares that could not be definitively determined in the original filing; no other changes to the original 8-K were made.
Why It Matters
- The amendment finalizes how many shares PAR issued as part of the Cardlytics asset acquisition, which affects PAR’s issued share count and potential dilution for existing shareholders.
- Retail investors should note this completes disclosure around the equity component of the deal; check PAR’s other filings for the exact share count and any updates to shares outstanding or related financial impacts.
Loading document...